Pharma & Healthcare
Nasal Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Nov 05, 24
- ID: 657547
- Pages: 125
- Figures: 238
- Views: 3
The global market for Nasal Vaccines was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nasal Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Nasal Vaccines by region & country, by Type, and by Application.
The Nasal Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nasal Vaccines.
Market Segmentation
By Company
Sanofi
AstraZeneca
Abbott
GlaxoSmithKline
Serum Institute of India
Bharat Biotech
Antares Pharma
INJEX Pharma GmbH
BioDiem
PharmaJet and Crossject
Segment by Type:
Flu Vaccines
COVID-19 Vaccines
Other Vaccines
Segment by Application
Adult
Children
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Nasal Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Nasal Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Nasal Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nasal Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Nasal Vaccines by region & country, by Type, and by Application.
The Nasal Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nasal Vaccines.
Market Segmentation
By Company
Sanofi
AstraZeneca
Abbott
GlaxoSmithKline
Serum Institute of India
Bharat Biotech
Antares Pharma
INJEX Pharma GmbH
BioDiem
PharmaJet and Crossject
Segment by Type:
Flu Vaccines
COVID-19 Vaccines
Other Vaccines
Segment by Application
Adult
Children
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Nasal Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Nasal Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Nasal Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Nasal Vaccines Product Introduction
1.2 Global Nasal Vaccines Market Size Forecast
1.2.1 Global Nasal Vaccines Sales Value (2019-2030)
1.2.2 Global Nasal Vaccines Sales Volume (2019-2030)
1.2.3 Global Nasal Vaccines Sales Price (2019-2030)
1.3 Nasal Vaccines Market Trends & Drivers
1.3.1 Nasal Vaccines Industry Trends
1.3.2 Nasal Vaccines Market Drivers & Opportunity
1.3.3 Nasal Vaccines Market Challenges
1.3.4 Nasal Vaccines Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Nasal Vaccines Players Revenue Ranking (2023)
2.2 Global Nasal Vaccines Revenue by Company (2019-2024)
2.3 Global Nasal Vaccines Players Sales Volume Ranking (2023)
2.4 Global Nasal Vaccines Sales Volume by Company Players (2019-2024)
2.5 Global Nasal Vaccines Average Price by Company (2019-2024)
2.6 Key Manufacturers Nasal Vaccines Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Nasal Vaccines Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Nasal Vaccines
2.9 Nasal Vaccines Market Competitive Analysis
2.9.1 Nasal Vaccines Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Nasal Vaccines Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nasal Vaccines as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Flu Vaccines
3.1.2 COVID-19 Vaccines
3.1.3 Other Vaccines
3.2 Global Nasal Vaccines Sales Value by Type
3.2.1 Global Nasal Vaccines Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Nasal Vaccines Sales Value, by Type (2019-2030)
3.2.3 Global Nasal Vaccines Sales Value, by Type (%) (2019-2030)
3.3 Global Nasal Vaccines Sales Volume by Type
3.3.1 Global Nasal Vaccines Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Nasal Vaccines Sales Volume, by Type (2019-2030)
3.3.3 Global Nasal Vaccines Sales Volume, by Type (%) (2019-2030)
3.4 Global Nasal Vaccines Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Adult
4.1.2 Children
4.2 Global Nasal Vaccines Sales Value by Application
4.2.1 Global Nasal Vaccines Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Nasal Vaccines Sales Value, by Application (2019-2030)
4.2.3 Global Nasal Vaccines Sales Value, by Application (%) (2019-2030)
4.3 Global Nasal Vaccines Sales Volume by Application
4.3.1 Global Nasal Vaccines Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Nasal Vaccines Sales Volume, by Application (2019-2030)
4.3.3 Global Nasal Vaccines Sales Volume, by Application (%) (2019-2030)
4.4 Global Nasal Vaccines Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Nasal Vaccines Sales Value by Region
5.1.1 Global Nasal Vaccines Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Nasal Vaccines Sales Value by Region (2019-2024)
5.1.3 Global Nasal Vaccines Sales Value by Region (2025-2030)
5.1.4 Global Nasal Vaccines Sales Value by Region (%), (2019-2030)
5.2 Global Nasal Vaccines Sales Volume by Region
5.2.1 Global Nasal Vaccines Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Nasal Vaccines Sales Volume by Region (2019-2024)
5.2.3 Global Nasal Vaccines Sales Volume by Region (2025-2030)
5.2.4 Global Nasal Vaccines Sales Volume by Region (%), (2019-2030)
5.3 Global Nasal Vaccines Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Nasal Vaccines Sales Value, 2019-2030
5.4.2 North America Nasal Vaccines Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Nasal Vaccines Sales Value, 2019-2030
5.5.2 Europe Nasal Vaccines Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Nasal Vaccines Sales Value, 2019-2030
5.6.2 Asia Pacific Nasal Vaccines Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Nasal Vaccines Sales Value, 2019-2030
5.7.2 South America Nasal Vaccines Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Nasal Vaccines Sales Value, 2019-2030
5.8.2 Middle East & Africa Nasal Vaccines Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Nasal Vaccines Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Nasal Vaccines Sales Value
6.2.1 Key Countries/Regions Nasal Vaccines Sales Value, 2019-2030
6.2.2 Key Countries/Regions Nasal Vaccines Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Nasal Vaccines Sales Value, 2019-2030
6.3.2 United States Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Nasal Vaccines Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Nasal Vaccines Sales Value, 2019-2030
6.4.2 Europe Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Nasal Vaccines Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Nasal Vaccines Sales Value, 2019-2030
6.5.2 China Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
6.5.3 China Nasal Vaccines Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Nasal Vaccines Sales Value, 2019-2030
6.6.2 Japan Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Nasal Vaccines Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Nasal Vaccines Sales Value, 2019-2030
6.7.2 South Korea Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Nasal Vaccines Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Nasal Vaccines Sales Value, 2019-2030
6.8.2 Southeast Asia Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Nasal Vaccines Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Nasal Vaccines Sales Value, 2019-2030
6.9.2 India Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
6.9.3 India Nasal Vaccines Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Company Information
7.1.2 Sanofi Introduction and Business Overview
7.1.3 Sanofi Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Sanofi Nasal Vaccines Product Offerings
7.1.5 Sanofi Recent Development
7.2 AstraZeneca
7.2.1 AstraZeneca Company Information
7.2.2 AstraZeneca Introduction and Business Overview
7.2.3 AstraZeneca Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.2.4 AstraZeneca Nasal Vaccines Product Offerings
7.2.5 AstraZeneca Recent Development
7.3 Abbott
7.3.1 Abbott Company Information
7.3.2 Abbott Introduction and Business Overview
7.3.3 Abbott Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Abbott Nasal Vaccines Product Offerings
7.3.5 Abbott Recent Development
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Information
7.4.2 GlaxoSmithKline Introduction and Business Overview
7.4.3 GlaxoSmithKline Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.4.4 GlaxoSmithKline Nasal Vaccines Product Offerings
7.4.5 GlaxoSmithKline Recent Development
7.5 Serum Institute of India
7.5.1 Serum Institute of India Company Information
7.5.2 Serum Institute of India Introduction and Business Overview
7.5.3 Serum Institute of India Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Serum Institute of India Nasal Vaccines Product Offerings
7.5.5 Serum Institute of India Recent Development
7.6 Bharat Biotech
7.6.1 Bharat Biotech Company Information
7.6.2 Bharat Biotech Introduction and Business Overview
7.6.3 Bharat Biotech Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Bharat Biotech Nasal Vaccines Product Offerings
7.6.5 Bharat Biotech Recent Development
7.7 Antares Pharma
7.7.1 Antares Pharma Company Information
7.7.2 Antares Pharma Introduction and Business Overview
7.7.3 Antares Pharma Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Antares Pharma Nasal Vaccines Product Offerings
7.7.5 Antares Pharma Recent Development
7.8 INJEX Pharma GmbH
7.8.1 INJEX Pharma GmbH Company Information
7.8.2 INJEX Pharma GmbH Introduction and Business Overview
7.8.3 INJEX Pharma GmbH Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.8.4 INJEX Pharma GmbH Nasal Vaccines Product Offerings
7.8.5 INJEX Pharma GmbH Recent Development
7.9 BioDiem
7.9.1 BioDiem Company Information
7.9.2 BioDiem Introduction and Business Overview
7.9.3 BioDiem Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.9.4 BioDiem Nasal Vaccines Product Offerings
7.9.5 BioDiem Recent Development
7.10 PharmaJet and Crossject
7.10.1 PharmaJet and Crossject Company Information
7.10.2 PharmaJet and Crossject Introduction and Business Overview
7.10.3 PharmaJet and Crossject Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.10.4 PharmaJet and Crossject Nasal Vaccines Product Offerings
7.10.5 PharmaJet and Crossject Recent Development
8 Industry Chain Analysis
8.1 Nasal Vaccines Industrial Chain
8.2 Nasal Vaccines Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Nasal Vaccines Sales Model
8.5.2 Sales Channel
8.5.3 Nasal Vaccines Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Nasal Vaccines Product Introduction
1.2 Global Nasal Vaccines Market Size Forecast
1.2.1 Global Nasal Vaccines Sales Value (2019-2030)
1.2.2 Global Nasal Vaccines Sales Volume (2019-2030)
1.2.3 Global Nasal Vaccines Sales Price (2019-2030)
1.3 Nasal Vaccines Market Trends & Drivers
1.3.1 Nasal Vaccines Industry Trends
1.3.2 Nasal Vaccines Market Drivers & Opportunity
1.3.3 Nasal Vaccines Market Challenges
1.3.4 Nasal Vaccines Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Nasal Vaccines Players Revenue Ranking (2023)
2.2 Global Nasal Vaccines Revenue by Company (2019-2024)
2.3 Global Nasal Vaccines Players Sales Volume Ranking (2023)
2.4 Global Nasal Vaccines Sales Volume by Company Players (2019-2024)
2.5 Global Nasal Vaccines Average Price by Company (2019-2024)
2.6 Key Manufacturers Nasal Vaccines Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Nasal Vaccines Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Nasal Vaccines
2.9 Nasal Vaccines Market Competitive Analysis
2.9.1 Nasal Vaccines Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Nasal Vaccines Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nasal Vaccines as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Flu Vaccines
3.1.2 COVID-19 Vaccines
3.1.3 Other Vaccines
3.2 Global Nasal Vaccines Sales Value by Type
3.2.1 Global Nasal Vaccines Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Nasal Vaccines Sales Value, by Type (2019-2030)
3.2.3 Global Nasal Vaccines Sales Value, by Type (%) (2019-2030)
3.3 Global Nasal Vaccines Sales Volume by Type
3.3.1 Global Nasal Vaccines Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Nasal Vaccines Sales Volume, by Type (2019-2030)
3.3.3 Global Nasal Vaccines Sales Volume, by Type (%) (2019-2030)
3.4 Global Nasal Vaccines Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Adult
4.1.2 Children
4.2 Global Nasal Vaccines Sales Value by Application
4.2.1 Global Nasal Vaccines Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Nasal Vaccines Sales Value, by Application (2019-2030)
4.2.3 Global Nasal Vaccines Sales Value, by Application (%) (2019-2030)
4.3 Global Nasal Vaccines Sales Volume by Application
4.3.1 Global Nasal Vaccines Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Nasal Vaccines Sales Volume, by Application (2019-2030)
4.3.3 Global Nasal Vaccines Sales Volume, by Application (%) (2019-2030)
4.4 Global Nasal Vaccines Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Nasal Vaccines Sales Value by Region
5.1.1 Global Nasal Vaccines Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Nasal Vaccines Sales Value by Region (2019-2024)
5.1.3 Global Nasal Vaccines Sales Value by Region (2025-2030)
5.1.4 Global Nasal Vaccines Sales Value by Region (%), (2019-2030)
5.2 Global Nasal Vaccines Sales Volume by Region
5.2.1 Global Nasal Vaccines Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Nasal Vaccines Sales Volume by Region (2019-2024)
5.2.3 Global Nasal Vaccines Sales Volume by Region (2025-2030)
5.2.4 Global Nasal Vaccines Sales Volume by Region (%), (2019-2030)
5.3 Global Nasal Vaccines Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Nasal Vaccines Sales Value, 2019-2030
5.4.2 North America Nasal Vaccines Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Nasal Vaccines Sales Value, 2019-2030
5.5.2 Europe Nasal Vaccines Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Nasal Vaccines Sales Value, 2019-2030
5.6.2 Asia Pacific Nasal Vaccines Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Nasal Vaccines Sales Value, 2019-2030
5.7.2 South America Nasal Vaccines Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Nasal Vaccines Sales Value, 2019-2030
5.8.2 Middle East & Africa Nasal Vaccines Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Nasal Vaccines Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Nasal Vaccines Sales Value
6.2.1 Key Countries/Regions Nasal Vaccines Sales Value, 2019-2030
6.2.2 Key Countries/Regions Nasal Vaccines Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Nasal Vaccines Sales Value, 2019-2030
6.3.2 United States Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Nasal Vaccines Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Nasal Vaccines Sales Value, 2019-2030
6.4.2 Europe Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Nasal Vaccines Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Nasal Vaccines Sales Value, 2019-2030
6.5.2 China Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
6.5.3 China Nasal Vaccines Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Nasal Vaccines Sales Value, 2019-2030
6.6.2 Japan Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Nasal Vaccines Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Nasal Vaccines Sales Value, 2019-2030
6.7.2 South Korea Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Nasal Vaccines Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Nasal Vaccines Sales Value, 2019-2030
6.8.2 Southeast Asia Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Nasal Vaccines Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Nasal Vaccines Sales Value, 2019-2030
6.9.2 India Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
6.9.3 India Nasal Vaccines Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Company Information
7.1.2 Sanofi Introduction and Business Overview
7.1.3 Sanofi Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Sanofi Nasal Vaccines Product Offerings
7.1.5 Sanofi Recent Development
7.2 AstraZeneca
7.2.1 AstraZeneca Company Information
7.2.2 AstraZeneca Introduction and Business Overview
7.2.3 AstraZeneca Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.2.4 AstraZeneca Nasal Vaccines Product Offerings
7.2.5 AstraZeneca Recent Development
7.3 Abbott
7.3.1 Abbott Company Information
7.3.2 Abbott Introduction and Business Overview
7.3.3 Abbott Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Abbott Nasal Vaccines Product Offerings
7.3.5 Abbott Recent Development
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Information
7.4.2 GlaxoSmithKline Introduction and Business Overview
7.4.3 GlaxoSmithKline Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.4.4 GlaxoSmithKline Nasal Vaccines Product Offerings
7.4.5 GlaxoSmithKline Recent Development
7.5 Serum Institute of India
7.5.1 Serum Institute of India Company Information
7.5.2 Serum Institute of India Introduction and Business Overview
7.5.3 Serum Institute of India Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Serum Institute of India Nasal Vaccines Product Offerings
7.5.5 Serum Institute of India Recent Development
7.6 Bharat Biotech
7.6.1 Bharat Biotech Company Information
7.6.2 Bharat Biotech Introduction and Business Overview
7.6.3 Bharat Biotech Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Bharat Biotech Nasal Vaccines Product Offerings
7.6.5 Bharat Biotech Recent Development
7.7 Antares Pharma
7.7.1 Antares Pharma Company Information
7.7.2 Antares Pharma Introduction and Business Overview
7.7.3 Antares Pharma Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Antares Pharma Nasal Vaccines Product Offerings
7.7.5 Antares Pharma Recent Development
7.8 INJEX Pharma GmbH
7.8.1 INJEX Pharma GmbH Company Information
7.8.2 INJEX Pharma GmbH Introduction and Business Overview
7.8.3 INJEX Pharma GmbH Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.8.4 INJEX Pharma GmbH Nasal Vaccines Product Offerings
7.8.5 INJEX Pharma GmbH Recent Development
7.9 BioDiem
7.9.1 BioDiem Company Information
7.9.2 BioDiem Introduction and Business Overview
7.9.3 BioDiem Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.9.4 BioDiem Nasal Vaccines Product Offerings
7.9.5 BioDiem Recent Development
7.10 PharmaJet and Crossject
7.10.1 PharmaJet and Crossject Company Information
7.10.2 PharmaJet and Crossject Introduction and Business Overview
7.10.3 PharmaJet and Crossject Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.10.4 PharmaJet and Crossject Nasal Vaccines Product Offerings
7.10.5 PharmaJet and Crossject Recent Development
8 Industry Chain Analysis
8.1 Nasal Vaccines Industrial Chain
8.2 Nasal Vaccines Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Nasal Vaccines Sales Model
8.5.2 Sales Channel
8.5.3 Nasal Vaccines Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Nasal Vaccines Market Trends
Table 2. Nasal Vaccines Market Drivers & Opportunity
Table 3. Nasal Vaccines Market Challenges
Table 4. Nasal Vaccines Market Restraints
Table 5. Global Nasal Vaccines Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Nasal Vaccines Revenue Market Share by Company (2019-2024)
Table 7. Global Nasal Vaccines Sales Volume by Company (2019-2024) & (K Dose)
Table 8. Global Nasal Vaccines Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Nasal Vaccines Price by Company (2019-2024) & (US$/Dose)
Table 10. Key Manufacturers Nasal Vaccines Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Nasal Vaccines Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Nasal Vaccines
Table 13. Global Nasal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nasal Vaccines as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Nasal Vaccines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Nasal Vaccines Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Nasal Vaccines Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Nasal Vaccines Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Nasal Vaccines Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Nasal Vaccines Sales Volume by Type: 2019 VS 2023 VS 2030 (K Dose)
Table 22. Global Nasal Vaccines Sales Volume by Type (2019-2024) & (K Dose)
Table 23. Global Nasal Vaccines Sales Volume by Type (2025-2030) & (K Dose)
Table 24. Global Nasal Vaccines Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Nasal Vaccines Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Nasal Vaccines Price by Type (2019-2024) & (US$/Dose)
Table 27. Global Nasal Vaccines Price by Type (2025-2030) & (US$/Dose)
Table 28. Global Nasal Vaccines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Nasal Vaccines Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Nasal Vaccines Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Nasal Vaccines Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Nasal Vaccines Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Nasal Vaccines Sales Volume by Application: 2019 VS 2023 VS 2030 (K Dose)
Table 34. Global Nasal Vaccines Sales Volume by Application (2019-2024) & (K Dose)
Table 35. Global Nasal Vaccines Sales Volume by Application (2025-2030) & (K Dose)
Table 36. Global Nasal Vaccines Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Nasal Vaccines Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Nasal Vaccines Price by Application (2019-2024) & (US$/Dose)
Table 39. Global Nasal Vaccines Price by Application (2025-2030) & (US$/Dose)
Table 40. Global Nasal Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Nasal Vaccines Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Nasal Vaccines Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Nasal Vaccines Sales Value by Region (2019-2024) & (%)
Table 44. Global Nasal Vaccines Sales Value by Region (2025-2030) & (%)
Table 45. Global Nasal Vaccines Sales Volume by Region (K Dose): 2019 VS 2023 VS 2030
Table 46. Global Nasal Vaccines Sales Volume by Region (2019-2024) & (K Dose)
Table 47. Global Nasal Vaccines Sales Volume by Region (2025-2030) & (K Dose)
Table 48. Global Nasal Vaccines Sales Volume by Region (2019-2024) & (%)
Table 49. Global Nasal Vaccines Sales Volume by Region (2025-2030) & (%)
Table 50. Global Nasal Vaccines Average Price by Region (2019-2024) & (US$/Dose)
Table 51. Global Nasal Vaccines Average Price by Region (2025-2030) & (US$/Dose)
Table 52. Key Countries/Regions Nasal Vaccines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Nasal Vaccines Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Nasal Vaccines Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Nasal Vaccines Sales Volume, (2019-2024) & (K Dose)
Table 56. Key Countries/Regions Nasal Vaccines Sales Volume, (2025-2030) & (K Dose)
Table 57. Sanofi Company Information
Table 58. Sanofi Introduction and Business Overview
Table 59. Sanofi Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 60. Sanofi Nasal Vaccines Product Offerings
Table 61. Sanofi Recent Development
Table 62. AstraZeneca Company Information
Table 63. AstraZeneca Introduction and Business Overview
Table 64. AstraZeneca Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 65. AstraZeneca Nasal Vaccines Product Offerings
Table 66. AstraZeneca Recent Development
Table 67. Abbott Company Information
Table 68. Abbott Introduction and Business Overview
Table 69. Abbott Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 70. Abbott Nasal Vaccines Product Offerings
Table 71. Abbott Recent Development
Table 72. GlaxoSmithKline Company Information
Table 73. GlaxoSmithKline Introduction and Business Overview
Table 74. GlaxoSmithKline Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 75. GlaxoSmithKline Nasal Vaccines Product Offerings
Table 76. GlaxoSmithKline Recent Development
Table 77. Serum Institute of India Company Information
Table 78. Serum Institute of India Introduction and Business Overview
Table 79. Serum Institute of India Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 80. Serum Institute of India Nasal Vaccines Product Offerings
Table 81. Serum Institute of India Recent Development
Table 82. Bharat Biotech Company Information
Table 83. Bharat Biotech Introduction and Business Overview
Table 84. Bharat Biotech Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 85. Bharat Biotech Nasal Vaccines Product Offerings
Table 86. Bharat Biotech Recent Development
Table 87. Antares Pharma Company Information
Table 88. Antares Pharma Introduction and Business Overview
Table 89. Antares Pharma Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 90. Antares Pharma Nasal Vaccines Product Offerings
Table 91. Antares Pharma Recent Development
Table 92. INJEX Pharma GmbH Company Information
Table 93. INJEX Pharma GmbH Introduction and Business Overview
Table 94. INJEX Pharma GmbH Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 95. INJEX Pharma GmbH Nasal Vaccines Product Offerings
Table 96. INJEX Pharma GmbH Recent Development
Table 97. BioDiem Company Information
Table 98. BioDiem Introduction and Business Overview
Table 99. BioDiem Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 100. BioDiem Nasal Vaccines Product Offerings
Table 101. BioDiem Recent Development
Table 102. PharmaJet and Crossject Company Information
Table 103. PharmaJet and Crossject Introduction and Business Overview
Table 104. PharmaJet and Crossject Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 105. PharmaJet and Crossject Nasal Vaccines Product Offerings
Table 106. PharmaJet and Crossject Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Nasal Vaccines Downstream Customers
Table 110. Nasal Vaccines Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Nasal Vaccines Product Picture
Figure 2. Global Nasal Vaccines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Nasal Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Nasal Vaccines Sales Volume (2019-2030) & (K Dose)
Figure 5. Global Nasal Vaccines Sales Price (2019-2030) & (US$/Dose)
Figure 6. Nasal Vaccines Report Years Considered
Figure 7. Global Nasal Vaccines Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Nasal Vaccines Players Sales Volume Ranking (2023) & (K Dose)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Nasal Vaccines Revenue in 2023
Figure 10. Nasal Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Flu Vaccines Picture
Figure 12. COVID-19 Vaccines Picture
Figure 13. Other Vaccines Picture
Figure 14. Global Nasal Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Nasal Vaccines Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Nasal Vaccines Sales Volume by Type (2019 VS 2023 VS 2030) & (K Dose)
Figure 17. Global Nasal Vaccines Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Nasal Vaccines Price by Type (2019-2030) & (US$/Dose)
Figure 19. Product Picture of Adult
Figure 20. Product Picture of Children
Figure 21. Global Nasal Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Nasal Vaccines Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Nasal Vaccines Sales Volume by Application (2019 VS 2023 VS 2030) & (K Dose)
Figure 24. Global Nasal Vaccines Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Nasal Vaccines Price by Application (2019-2030) & (US$/Dose)
Figure 26. North America Nasal Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Nasal Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Nasal Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Nasal Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Nasal Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Nasal Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Nasal Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Nasal Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Nasal Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Nasal Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Nasal Vaccines Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Nasal Vaccines Sales Volume (%), (2019-2030)
Figure 38. United States Nasal Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Nasal Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Nasal Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Nasal Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 44. China Nasal Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 46. China Nasal Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Nasal Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Nasal Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Nasal Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Nasal Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Nasal Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Nasal Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 56. India Nasal Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 58. India Nasal Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 59. Nasal Vaccines Industrial Chain
Figure 60. Nasal Vaccines Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Nasal Vaccines Market Trends
Table 2. Nasal Vaccines Market Drivers & Opportunity
Table 3. Nasal Vaccines Market Challenges
Table 4. Nasal Vaccines Market Restraints
Table 5. Global Nasal Vaccines Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Nasal Vaccines Revenue Market Share by Company (2019-2024)
Table 7. Global Nasal Vaccines Sales Volume by Company (2019-2024) & (K Dose)
Table 8. Global Nasal Vaccines Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Nasal Vaccines Price by Company (2019-2024) & (US$/Dose)
Table 10. Key Manufacturers Nasal Vaccines Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Nasal Vaccines Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Nasal Vaccines
Table 13. Global Nasal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nasal Vaccines as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Nasal Vaccines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Nasal Vaccines Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Nasal Vaccines Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Nasal Vaccines Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Nasal Vaccines Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Nasal Vaccines Sales Volume by Type: 2019 VS 2023 VS 2030 (K Dose)
Table 22. Global Nasal Vaccines Sales Volume by Type (2019-2024) & (K Dose)
Table 23. Global Nasal Vaccines Sales Volume by Type (2025-2030) & (K Dose)
Table 24. Global Nasal Vaccines Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Nasal Vaccines Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Nasal Vaccines Price by Type (2019-2024) & (US$/Dose)
Table 27. Global Nasal Vaccines Price by Type (2025-2030) & (US$/Dose)
Table 28. Global Nasal Vaccines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Nasal Vaccines Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Nasal Vaccines Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Nasal Vaccines Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Nasal Vaccines Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Nasal Vaccines Sales Volume by Application: 2019 VS 2023 VS 2030 (K Dose)
Table 34. Global Nasal Vaccines Sales Volume by Application (2019-2024) & (K Dose)
Table 35. Global Nasal Vaccines Sales Volume by Application (2025-2030) & (K Dose)
Table 36. Global Nasal Vaccines Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Nasal Vaccines Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Nasal Vaccines Price by Application (2019-2024) & (US$/Dose)
Table 39. Global Nasal Vaccines Price by Application (2025-2030) & (US$/Dose)
Table 40. Global Nasal Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Nasal Vaccines Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Nasal Vaccines Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Nasal Vaccines Sales Value by Region (2019-2024) & (%)
Table 44. Global Nasal Vaccines Sales Value by Region (2025-2030) & (%)
Table 45. Global Nasal Vaccines Sales Volume by Region (K Dose): 2019 VS 2023 VS 2030
Table 46. Global Nasal Vaccines Sales Volume by Region (2019-2024) & (K Dose)
Table 47. Global Nasal Vaccines Sales Volume by Region (2025-2030) & (K Dose)
Table 48. Global Nasal Vaccines Sales Volume by Region (2019-2024) & (%)
Table 49. Global Nasal Vaccines Sales Volume by Region (2025-2030) & (%)
Table 50. Global Nasal Vaccines Average Price by Region (2019-2024) & (US$/Dose)
Table 51. Global Nasal Vaccines Average Price by Region (2025-2030) & (US$/Dose)
Table 52. Key Countries/Regions Nasal Vaccines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Nasal Vaccines Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Nasal Vaccines Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Nasal Vaccines Sales Volume, (2019-2024) & (K Dose)
Table 56. Key Countries/Regions Nasal Vaccines Sales Volume, (2025-2030) & (K Dose)
Table 57. Sanofi Company Information
Table 58. Sanofi Introduction and Business Overview
Table 59. Sanofi Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 60. Sanofi Nasal Vaccines Product Offerings
Table 61. Sanofi Recent Development
Table 62. AstraZeneca Company Information
Table 63. AstraZeneca Introduction and Business Overview
Table 64. AstraZeneca Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 65. AstraZeneca Nasal Vaccines Product Offerings
Table 66. AstraZeneca Recent Development
Table 67. Abbott Company Information
Table 68. Abbott Introduction and Business Overview
Table 69. Abbott Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 70. Abbott Nasal Vaccines Product Offerings
Table 71. Abbott Recent Development
Table 72. GlaxoSmithKline Company Information
Table 73. GlaxoSmithKline Introduction and Business Overview
Table 74. GlaxoSmithKline Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 75. GlaxoSmithKline Nasal Vaccines Product Offerings
Table 76. GlaxoSmithKline Recent Development
Table 77. Serum Institute of India Company Information
Table 78. Serum Institute of India Introduction and Business Overview
Table 79. Serum Institute of India Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 80. Serum Institute of India Nasal Vaccines Product Offerings
Table 81. Serum Institute of India Recent Development
Table 82. Bharat Biotech Company Information
Table 83. Bharat Biotech Introduction and Business Overview
Table 84. Bharat Biotech Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 85. Bharat Biotech Nasal Vaccines Product Offerings
Table 86. Bharat Biotech Recent Development
Table 87. Antares Pharma Company Information
Table 88. Antares Pharma Introduction and Business Overview
Table 89. Antares Pharma Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 90. Antares Pharma Nasal Vaccines Product Offerings
Table 91. Antares Pharma Recent Development
Table 92. INJEX Pharma GmbH Company Information
Table 93. INJEX Pharma GmbH Introduction and Business Overview
Table 94. INJEX Pharma GmbH Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 95. INJEX Pharma GmbH Nasal Vaccines Product Offerings
Table 96. INJEX Pharma GmbH Recent Development
Table 97. BioDiem Company Information
Table 98. BioDiem Introduction and Business Overview
Table 99. BioDiem Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 100. BioDiem Nasal Vaccines Product Offerings
Table 101. BioDiem Recent Development
Table 102. PharmaJet and Crossject Company Information
Table 103. PharmaJet and Crossject Introduction and Business Overview
Table 104. PharmaJet and Crossject Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 105. PharmaJet and Crossject Nasal Vaccines Product Offerings
Table 106. PharmaJet and Crossject Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Nasal Vaccines Downstream Customers
Table 110. Nasal Vaccines Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Nasal Vaccines Product Picture
Figure 2. Global Nasal Vaccines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Nasal Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Nasal Vaccines Sales Volume (2019-2030) & (K Dose)
Figure 5. Global Nasal Vaccines Sales Price (2019-2030) & (US$/Dose)
Figure 6. Nasal Vaccines Report Years Considered
Figure 7. Global Nasal Vaccines Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Nasal Vaccines Players Sales Volume Ranking (2023) & (K Dose)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Nasal Vaccines Revenue in 2023
Figure 10. Nasal Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Flu Vaccines Picture
Figure 12. COVID-19 Vaccines Picture
Figure 13. Other Vaccines Picture
Figure 14. Global Nasal Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Nasal Vaccines Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Nasal Vaccines Sales Volume by Type (2019 VS 2023 VS 2030) & (K Dose)
Figure 17. Global Nasal Vaccines Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Nasal Vaccines Price by Type (2019-2030) & (US$/Dose)
Figure 19. Product Picture of Adult
Figure 20. Product Picture of Children
Figure 21. Global Nasal Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Nasal Vaccines Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Nasal Vaccines Sales Volume by Application (2019 VS 2023 VS 2030) & (K Dose)
Figure 24. Global Nasal Vaccines Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Nasal Vaccines Price by Application (2019-2030) & (US$/Dose)
Figure 26. North America Nasal Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Nasal Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Nasal Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Nasal Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Nasal Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Nasal Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Nasal Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Nasal Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Nasal Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Nasal Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Nasal Vaccines Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Nasal Vaccines Sales Volume (%), (2019-2030)
Figure 38. United States Nasal Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Nasal Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Nasal Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Nasal Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 44. China Nasal Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 46. China Nasal Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Nasal Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Nasal Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Nasal Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Nasal Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Nasal Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Nasal Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 56. India Nasal Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Nasal Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 58. India Nasal Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 59. Nasal Vaccines Industrial Chain
Figure 60. Nasal Vaccines Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232